Data completeness
0/8 — Limited
Drug data last refreshed 2h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NEOSPORIN is a topical cream formulation by GSK indicated for minor wound care and skin infections. The product contains a combination of antibiotics (neomycin, polymyxin B, and bacitracin) that work synergistically to prevent bacterial infection. It is a small-molecule antibiotic combination therapy applied directly to affected skin.
Pre-Launch
Pre-launch stage offers limited commercial clarity; team size and trajectory depend on GSK's strategic commitment to OTC topical dermatology.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
NEOSPORIN is a pre-launch OTC topical product with limited current job visibility. Career roles focus on launch commercialization, regulatory compliance, and market access in the mature wound care category. This is a niche opportunity for professionals targeting consumer health or OTC dermatology portfolios.
Brand ManagerField Sales Representative
Worked on NEOSPORIN at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.